Keywords: EES، everolimus-eluting stent (s); drug-eluting stent(s); dual antiplatelet therapy; everolimus; stent thrombosisBMS, bare-metal stent(s); CI, confidence interval; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio; MACCE, major
مقالات ISI EES، everolimus-eluting stent (s) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: EES، everolimus-eluting stent (s); BA, balloon angioplasty; BMS, bare-metal stent(s); CB, cutting balloon angioplasty; CCS, Canadian Cardiovascular Society; EES, everolimus-eluting stent(s); ISR, in-stent restenosis; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); TIMI,
Keywords: EES، everolimus-eluting stent (s); animals; bioresorbable scaffold; coronary artery imaging; pathologyBVS, bioresorbable vascular scaffold(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); IVUS, intravascular ultrasound; LA, lumen area; MLD, mean lumen diameter; RLA, refere
Keywords: EES، everolimus-eluting stent (s); drug-eluting stent(s); incomplete stent apposition; intravascular ultrasound; optical coherence tomography; percutaneous coronary intervention; stent malappositionBMS, bare-metal stent(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); ISA,
Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity
Keywords: EES، everolimus-eluting stent (s); everolimus-eluting stent(s); left main disease; percutaneous coronary interventionCABG, coronary artery bypass graft; CTO, chronic total occlusion; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); EuroSCORE, European system for cardiac operat
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents : A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries
Keywords: EES، everolimus-eluting stent (s); bioresorbable scaffolds; drug-eluting stent(s); propensity scoreBRS, bioresorbable scaffold(s); DES, drug-eluting stent(s); DOCE, device-oriented composite endpoint; EES, everolimus-eluting stent(s); PCI, percutaneous coronary intervention
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis : 3-Year Follow-Up of the RIBS V Clinical Trial
Keywords: EES، everolimus-eluting stent (s); drug-eluting balloon(s); drug-eluting stent(s); everolimus-eluting stent(s); in-stent restenosisBMS, bare-metal stent(s); DEB, drug-eluting balloon(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); ISR, in-stent restenosis
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
Keywords: EES، everolimus-eluting stent (s); asymmetry; bioresorbable vascular scaffolds; eccentricity; expansionAI, asymmetry index; BVS, bioresorbable vascular scaffold; DES, drug-eluting stent(s); DoCE, device-oriented composite endpoint; EES, everolimus-eluting stent(s); EI, eccentricity index;
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents : The RIBS IV Randomized Clinical Trial
Keywords: EES، everolimus-eluting stent (s); angiography; percutaneous coronary intervention; proliferation; revascularizationBMS, bare-metal stent(s); DEB, drug-eluting balloon(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); ISR, in-stent restenosis; MI, myocardial infarction; MLD
The EXAMINATION Trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction) : 2-Year Results From a Multicenter Randomized Controlled Trial
Keywords: EES، everolimus-eluting stent (s); myocardial infarction; revascularization; stent(s); thrombosis; trialsBMS, bare-metal stent(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); STEMI, ST-segment elevation myocardial infarction
Comparison of Newer-Generation Drug-Eluting With Bare-Metal Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction : A Pooled Analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMF
Keywords: EES، everolimus-eluting stent (s); drug-eluting stent(s); STEMI; stent thrombosisBES, biolimus A9–eluting stent(s); BMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); DOCE, device-oriented composite endpoint; EES, everolimus-eluting stent(s); HR, hazard ratio; P
Mechanisms of Atherothrombosis and Vascular Response to Primary Percutaneous Coronary Intervention in Women Versus Men With Acute Myocardial Infarction : Results of the OCTAVIA Study
Keywords: EES، everolimus-eluting stent (s); etiology; myocardial infarction; myocardial revascularization; sex differencesCI, confidence interval; EES, everolimus-eluting stent(s); IQR, interquartile range; MI, myocardial infarction; OCT, optical coherence tomography; PCI, percutaneous coronary int
5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents : Final Results From the SPIRIT III Trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patien
Keywords: EES، everolimus-eluting stent (s); coronary artery disease; drug-eluting stent(s); in-stent restenosis; stent thrombosis; target vessel failureDES, drug-eluting stent(s); EES, everolimus-eluting stent(s); MACE, major adverse cardiac event(s); PES, paclitaxel-eluting stent(s); TLF, target l
Zotarolimus- Versus Everolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease
Keywords: EES، everolimus-eluting stent (s); coronary artery disease; drug-eluting stent(s); everolimus; left main coronary artery; restenosis; zotarolimusCABG, aortocoronary artery bypass graft; CI, confidence interval; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); LMCA, left main c
Randomized Comparison of Clinical Outcomes Between Intravascular Ultrasound and Angiography-Guided Drug-Eluting Stent Implantation for Long Coronary Artery Stenoses
Keywords: EES، everolimus-eluting stent (s); coronary artery disease; drug-eluting stent; intravascular ultrasoundCI, confidence intervals; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); E-ZES, Endeavor Sprint zotarolimus-eluting stent(s); IQR, interquartile range; IVUS, intravascular
Impact of Kissing Balloon Inflation on the Main Vessel Stent Volume, Area, and Symmetry After Side-Branch Dilation in Patients With Coronary Bifurcation Lesions : A Serial Volumetric Intravascular Ultrasound Study
Keywords: EES، everolimus-eluting stent (s); bifurcation lesions; IVUS; kissing balloon inflation; stentingCBL, coronary bifurcation lesions; DES, drug-eluting stent(s); EEM, external elastic membrane; EES, everolimus-eluting stent(s); ISA, incomplete stent apposition; IVUS, intravascular ultrasound
Serial Assessment of Vessel Interactions After Drug-Eluting Stent Implantation in Unprotected Distal Left Main Coronary Artery Disease Using Frequency-Domain Optical Coherence Tomography
Keywords: EES، everolimus-eluting stent (s); frequency-domain optical coherence tomography; percutaneous coronary intervention; unprotected left main coronary artery diseaseBIF, bifurcation; BODY, ostial-body; DES, drug-eluting stent(s); DIS, distal; EES, everolimus-eluting stent(s); FD-OCT, frequen
2-Year Patient-Related Versus Stent-Related Outcomes : The SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial
Keywords: EES، everolimus-eluting stent (s); drug-eluting stent; outcome; percutaneous coronary interventionCI, confidence interval; DES, drug eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio; MI, myocardial infarction; PCI, percutaneous coronary intervention; SES, sirolimus-elut
Quantitative and Qualitative Changes in DES-Related Neointimal Tissue Based on Serial OCT
Keywords: EES، everolimus-eluting stent (s); neointima; optical coherence tomography; stentCSA, cross-sectional area; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); NIH, neointimal hyperplasia; OCT, optical coherence tomography; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting
Everolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis : The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Dise
Keywords: EES، everolimus-eluting stent (s); bypass surgery; coronary disease; left main coronary disease; stentsaHR, adjusted hazard ratio; CABG, coronary artery bypass graft; CI, confidence interval; DES, drug-eluting stent(s); DS, diameter stenosis; EES, everolimus-eluting stent(s); HR, hazard ra
Long-Term Comparison of Everolimus- and Sirolimus-Eluting Stents in Patients With Acute Coronary Syndromes
Keywords: EES، everolimus-eluting stent (s); acute coronary syndrome(s); drug-eluting stent(s); everolimus-eluting stent(s); sirolimus-eluting stent(s)ACS, acute coronary syndrome(s); CI, confidence interval; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio; MI, myocard
Biodegradable Polymer Versus Permanent Polymer Drug-Eluting Stents and Everolimus- Versus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease : 3-Year Outcomes From a Randomized Clinical Trial
Keywords: EES، everolimus-eluting stent (s); biodegradable; drug-eluting stent; everolimus; polymer; randomized trial; restenosis; sirolimusCI, confidence interval; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio; MI, myocardial infarction; SES, sirolimus-eluting stent
Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents : 2-Year Follow-Up From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV Trial
Keywords: EES، everolimus-eluting stent (s); angioplasty; prognosis; stentDES, drug-eluting stent(s); EES, everolimus-eluting stent(s); MI, myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); TLF, target lesion failure; TLR, target lesion revascularizati
The SPIRIT V Study : A Clinical Evaluation of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions
Keywords: EES، everolimus-eluting stent (s); drug-eluting stent (DES); everolimus; percutaneous coronary intervention (PCI); stentARC, Academic Research Consortium; CABG, coronary artery bypass grafting; CI, confidence interval; EES, everolimus-eluting stent(s); ITT, intent-to-treat; MACE, major adv
2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice : COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent
Keywords: EES، everolimus-eluting stent (s); drug-eluting stent; myocardial infarction; stent thrombosisCI, confidence interval; DAPT, dual antiplatelet therapy; EES, everolimus-eluting stent(s); MI, myocardial infarction; PES, paclitaxel-eluting stent(s); RR, relative risk; SES, sirolimus-eluting s
Long-Term Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents for Coronary Revascularization
Keywords: EES، everolimus-eluting stent (s); coronary disease; drug-eluting stents; stent thrombosisCI, confidence interval; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio; MI, myocardial infarction; PES, paclitaxel-eluting stent(s); PS, propensity score; RR, relative
Prospective Randomized Comparison of Sirolimus- or Everolimus-Eluting Stent to Treat Bifurcated Lesions by Provisional Approach
Keywords: EES، everolimus-eluting stent (s); bifurcated lesions; drug-eluting stent(s); percutaneous coronary interventionsCK-MB, creatine kinase-myocardial band; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); MACE, major adverse coronary event(s); MI, myocardial infarction; MLA, mini
Impact of the Everolimus-Eluting Stent on Stent Thrombosis : A Meta-Analysis of 13 Randomized Trials
Keywords: EES، everolimus-eluting stent (s); drug-eluting stent; everolimus-eluting; stent thrombosisDAPT, dual-antiplatelet therapy; DES, drug-eluting stent(s); EE, everolimus-eluting; EES, everolimus-eluting stent(s); MI, myocardial infarction; PES, paclitaxel-eluting stent(s); SES, sirolimus-elut
The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents : A Substudy of the RESOLUTE All Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent
Keywords: EES، everolimus-eluting stent (s); complex; drug-eluting stent; everolimus; off-label; zotarolimusBMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); ECG, electrocardiogram/electrocardiographic; EES, everolimus-eluting stent(s); MI, myocardial infarction; ST, ste
Comparison of Everolimus- and Paclitaxel-Eluting Stents in Patients With Acute and Stable Coronary Syndromes : Pooled Results From the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolim
Keywords: EES، everolimus-eluting stent (s); acute coronary syndrome; drug-eluting stent(s); everolimus; paclitaxel; stent thrombosisACS, acute coronary syndrome(s); CAD, coronary artery disease; CI, confidence interval; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio;
Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents : Results From the SPIRIT IV Clinical Trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)
Keywords: EES، everolimus-eluting stent (s); diabetes; drug-eluting stent(s); everolimus; major adverse cardiac event(s)DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); ID-TLR, ischemia-driven target lesion revascularization; MACE, major adverse cardiac event(s); MI, myocardial infarcti
Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents : A Pooled Analysis From the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Art
Keywords: EES، everolimus-eluting stent (s); drug-eluting stent(s); percutaneous coronary intervention; randomized clinical trialARC, Academic Research Consortium; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); MACE, major adverse cardiac events; MI, myocardial infarction; PES, paclit
A Comparison of the Conformability of Everolimus-Eluting Bioresorbable Vascular Scaffolds to Metal Platform Coronary Stents
Keywords: EES، everolimus-eluting stent (s); angulation; bioresorbable; curvature; conformability; stentBVS, bioresorbable vascular scaffold(s); EES, everolimus-eluting stent(s); MPS, metallic platform stent(s); QCA, quantitative coronary angiography; WSS, wall shear stress; 2D, 2-dimensional
Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention : The SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System
Keywords: EES، everolimus-eluting stent (s); drug-eluting stent(s); everolimus; major adverse cardiac events; stentBMS, bare-metal stent(s); CABG, coronary artery bypass graft; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); ID-TLR, ischemia-driven target lesion revascularization; MACE
In-Stent Restenosis in the Drug-Eluting Stent Era
Keywords: EES، everolimus-eluting stent (s); drug-eluting stent(s); in-stent restenosis; target lesion revascularizationBMS, bare-metal stent(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); ISR, in-stent restenosis; IVUS, intravascular ultrasound; MI, myocardial infarction; PCI, pe
Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents
Keywords: EES، everolimus-eluting stent (s); drug-eluting stents; endothelium; platelet-endothelial adhesion molecule-1; vascular endothelial growth factorDES, drug-eluting stent(s); EES, everolimus-eluting stent(s); FDA, Food and Drug Administration; PECAM, platelet-endothelial cell adhesion molecu